AAAAAA
Results:
1-12
|
Results: 12
Authors:
Laperche, S
Girault, A
Beaulieu, MJ
Bouchardeau, F
Courouce, AM
Citation: S. Laperche et al., Determination of hepatitis B virus subtypes by an enzyme immunoassay method using monoclonal antibodies to type-specific epitopes of HBsAg, J VIRAL HEP, 8(6), 2001, pp. 447-453
Authors:
Ly, TD
Laperche, S
Courouce, AM
Citation: Td. Ly et al., Early detection of human immunodeficiency virus infection using third- andfourth-generation screening assays, EUR J CL M, 20(2), 2001, pp. 104-110
Authors:
Laperche, S
Maniez-Montreuil, M
Courouce, AM
Citation: S. Laperche et al., Combined tests (p24 Ag and anti-HIV antibodies) during early HIV-1 infection., MED MAL INF, 31(2), 2001, pp. 79-81
Authors:
Laperche, S
Maniez-Montreuil, M
Courouce, AM
Citation: S. Laperche et al., Combined tests (p24 Ag and anti-HIV antibodies) during early HIV-1 infection, MED MAL INF, 31(2), 2001, pp. 82-84
Authors:
Laperche, S
Guitton, C
Smilovici, W
Courouce, AM
Citation: S. Laperche et al., Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen, VOX SANGUIN, 80(2), 2001, pp. 90-94
Authors:
Barin, F
Laperche, S
Courouce, AM
Citation: F. Barin et al., The genetic diversity of viruses: consequences for blood screening and prevention of viral infection., TRANSF CL B, 7(5), 2000, pp. 472-478
Authors:
Laperche, S
Maniez-Montreuil, M
Courouce, AM
Citation: S. Laperche et al., p24 Ag/anti-HIV combined tests in early HIV-1 infection, TRANSF CL B, 7, 2000, pp. 18S-24S
Authors:
Lefrere, JJ
Lerable, J
Mariotti, M
Bogard, M
Thibault, V
Frangeul, L
Loiseau, P
Bouchardeau, F
Laperche, S
Pawlotsky, JM
Cantaloube, JF
Biagini, P
de Lamballerie, X
Izopet, J
Defer, C
Lepot, I
Poveda, JD
Dussaix, E
Gerolami, V
Halfon, P
Buffet-Janvresse, C
Ferec, C
Mercier, B
Marcellin, P
Martinot-Peignoux, M
Gassain, M
Merel, P
Lamoril, J
Coste, J
Roudet-Thoraval, F
Citation: Jj. Lefrere et al., Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay, J VIROL MET, 85(1-2), 2000, pp. 117-124
Authors:
Bouchardeau, F
Laperche, S
Pillonel, J
Elghouzzi, MH
Maisonneuve, P
Tirtaine, C
Boiret, E
Razer, A
Girault, A
Beaulieu, MJ
Courouce, AM
Citation: F. Bouchardeau et al., GB Virus type C/HGV markers in HCV RNA-positive French blood donors: correlation with HCV genotypes and risk factors, TRANSFUSION, 40(7), 2000, pp. 875-878
Authors:
Courouce, AM
Le Marrec, N
Bouchardeau, F
Razer, A
Maniez, M
Laperche, S
Simon, N
Citation: Am. Courouce et al., Efficacy of HCV core antigen detection during the preseroconversion period, TRANSFUSION, 40(10), 2000, pp. 1198-1202
Authors:
Laperche, S
Citation: S. Laperche, Creutzfeldt-Jakob disease and blood transfusion-related risk in 1998, TRANSF CL B, 6(1), 1999, pp. 67-71
Authors:
Desassis, JF
Laperche, S
Girault, A
Kolko, A
Bouchardeau, F
Zins, B
Poignet, JL
Courouce, AM
Citation: Jf. Desassis et al., Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre, NEPH DIAL T, 14(11), 1999, pp. 2692-2697
Risultati:
1-12
|